IRCT20190606043826N1已完成未知
Comparison of levofloxacin versus clarithromycin efficacy in bismuth-containing quadruple therapy for helicobacter pylori eradication
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 194
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 14 years 至 70 years（—）
- 性别
- All
入选标准
- •Positive h.pylori people have indications of treatment
- •Age between 14 and 70 years
- •Patients with informed consent to participate in the study
排除标准
- •Do not use the correct and regular drug
- •Incidence of unbearable side effects
- •Pregnancy and lactation
- •The presence of chronic liver, kidney and gastrointestinal diseases simultaneously
- •Previous history of h.pylori treatment in a recent month
研究者
相似试验
已完成
1 期
Comparison between levofluxain and clarithromycin treatment in helicobacter pylori eradicatioHelicobacter pylori.Diseases of oesophagus, stomach and duodenumK20-K31IRCT2015030421328N1Vice-chancellor Of Research, Daneshgah Square, Ganjafrooz Avenue80
尚未招募
3 期
Clarithromycin Based and Levofloxacin Based Quadruple Therapy in Helicobacter Pylori EradicatioIRCT20200929048884N1Ghoum University of Medical Sciences200
招募中
3 期
Eraddication of Helicobacter pylori for quadruple therapy with base of Clarithromycin compared with LevofloxaciHelicobacter pylori infection.Helicobacter pylorB96.81IRCT20171223038001N1Esfahan University of Medical Sciences210
已完成
3 期
Efficacy of Levofloxacin- containing versus Clarithromycin -containing Sequential Therapies in Helicobacter pylori Eradicatiogastric ulcer or erosion-deudenal ulcer or erosion.Gastric ulcer-Duodenal ulcer- Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersk25-K26 -BIRCT2015030820178N2Iran University of Medical Sciences,Rasoul Akram Hospital,Colorectal Research Center182
已完成
3 期
Comparison between clarithromycin and levofloxacin in treatment of H pyloriDigestive SystemHelicobacter pyloriPACTR202012742050337Benha University Hospital200